Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,459 papers from all fields of science
Search
Sign In
Create Free Account
Clodronate
Known as:
CLOD
A nitrogen-free bisphosphonate analog of naturally occurring pyrophosphate. Clodronate disodium binds to calcium and inhibits osteoclastic bone…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Narrower (6)
Bonefos
Clasteon
Clodronate Disodium
Clodronic Acid
Expand
clodronate/mitoxantrone/prednisone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Growth Factors , Cytokines , Cell Cycle Molecules Contribution of Macrophages to Angiogenesis Induced by Vascular Endothelial Growth Factor Receptor-3-Specific Ligands
E. Chung
,
S. Chauhan
,
+6 authors
R. Dana
2010
Corpus ID: 25007718
From the Schepens Eye Research Institute,* Harvard Medical School, Boston, Massachusetts; the Department of Ophthalmology…
Expand
Review
2008
Review
2008
Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
A. Lipton
Cancer Treatment Reviews
2008
Corpus ID: 25298276
Highly Cited
2005
Highly Cited
2005
Simultaneous enantioseparation and tandem UV-MS detection of eight beta-blockers in micellar electrokinetic chromatography using a chiral molecular micelle.
Cevdet Akbay
,
S. A. Rizvi
,
S. Shamsi
Analytical Chemistry
2005
Corpus ID: 34765313
The feasibility of using a new and more versatile polymeric chiral surfactant, i.e., poly(sodium N-undecenoxy carbonyl-L…
Expand
Review
2000
Review
2000
Oral bisphosphonates
P. Major
,
A. Lipton
,
James Berenson
,
G. Hortobagyi
Cancer
2000
Corpus ID: 29427931
This study was conducted to review the efficacy and safety of oral bisphosphonates for the treatment of bone metastases in cancer…
Expand
Highly Cited
1998
Highly Cited
1998
Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro.
Jukka Mönkkönen
,
Johanna Similä
,
M. J. Rogers
,
M. J. Rogers
Life Science
1998
Corpus ID: 36492638
Highly Cited
1997
Highly Cited
1997
Human Neutrophil Collagenase MMP-8 in Peri-implant Sulcus Fluid and its Inhibition by Clodronate
O. Teronen
,
Konttinen Yt
,
+6 authors
Timo Sorsa
Journal of dentistry research
1997
Corpus ID: 20293132
The exact molecular mechanisms of the loosening of a dental implant are not well-known. The characteristics of implant sulci are…
Expand
Highly Cited
1996
Highly Cited
1996
Calcitonin promotes osteoclast survival in vitro
K. Selander
,
P. Härkönen
,
E. Valve
,
J. Mönkkönen
,
R. Hannuniemi
,
H. Väänänen
Molecular and Cellular Endocrinology
1996
Corpus ID: 32415777
Highly Cited
1995
Highly Cited
1995
Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapy
P. Filipponi
,
M. Pedetti
,
+5 authors
S. Cristallini
Journal of Bone and Mineral Research
1995
Corpus ID: 23811238
An investigative study was carried out for 2 years involving 124 randomly selected early postmenopausal women with spine bone…
Expand
Highly Cited
1992
Highly Cited
1992
Effect of oral clodronate on bone pain
Inkeri Elomaa
,
T. Kylmälä
,
+8 authors
O. Alfthan
International Urology and Nephrology
1992
Corpus ID: 23303455
Although osteosclerotic metastases are characteristic of prostatic carcinoma, bone resorption is also accelerated. Since…
Expand
Highly Cited
1987
Highly Cited
1987
Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
I. Elomaa
,
Carl P. Blomqvist
,
L. Porkka
,
C. Lamberg-Allardt
,
Borgström Gh
Bone
1987
Corpus ID: 40351224
Normocalcaemic breast cancer patients with progressive osteolytic bone metastases were treated with clodronate 1.6 g/day (17) or…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE